Search

everythinglearnresearchcommunity

for

Search:↓

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Poor body image from pain can lead to more depression in lupus patients.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.